Cargando…
Cancer Cell Response to Anthracyclines Effects: Mysteries of the Hidden Proteins Associated with These Drugs
A comprehensive proteome map of T-lymphoblastic leukemia cells and its alterations after daunorubicin, doxorubicin and mitoxantrone treatments was monitored and evaluated either by paired comparison with relevant untreated control and using multivariate classification of treated and untreated sample...
Autores principales: | Tyleckova, Jirina, Hrabakova, Rita, Mairychova, Katerina, Halada, Petr, Radova, Lenka, Dzubak, Petr, Hajduch, Marian, Gadher, Suresh J., Kovarova, Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546648/ https://www.ncbi.nlm.nih.gov/pubmed/23443080 http://dx.doi.org/10.3390/ijms131215536 |
Ejemplares similares
-
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
por: Kotulová, Jana, et al.
Publicado: (2021) -
2-Cl-IB-MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines
por: Kotulova, Jana, et al.
Publicado: (2022) -
Evaluation of Non-Invasive Gargle Lavage Sampling for the Detection of SARS-CoV-2 Using rRT-PCR or Antigen Assay
por: Bouska, Ondrej, et al.
Publicado: (2022) -
Amino-BODIPY as the ratiometric fluorescent sensor for monitoring drug release or “power supply” selector for molecular electronics
por: Porubský, Martin, et al.
Publicado: (2019) -
Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2
por: Ćavar Zeljković, Sanja, et al.
Publicado: (2022)